HF
REPL icon

HRT Financial’s Replimune Group REPL Stock Holding History

HRT Financial’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-183,592
Closed -$1.4M – 4571
2025
Q4 		$1.78M Buy
183,592
+9,541
+5% +$81.1K 0.01% 1379
2025
Q3 		$729K Buy
174,051
+82,876
+91% +$530K ﹤0.01% 1683
2025
Q2 		$847K Buy
+91,175
New +$796K ﹤0.01% 1347
2025
Q1 		– Sell
-65,625
Closed -$794K – 3248
2024
Q4 		$794K Buy
+65,625
New +$797K ﹤0.01% 1198
2024
Q3 		– Sell
-184,761
Closed -$1.66M – 3013
2024
Q2 		$1.66M Buy
+184,761
New +$1.29M 0.01% 802
2023
Q3 		– Sell
-116,469
Closed -$2.7M – 2972
2023
Q2 		$2.7M Buy
+116,469
New +$2.28M 0.03% 483
2023
Q1 		– Sell
-44,437
Closed -$1.21M – 3074
2022
Q4 		$1.21M Buy
+44,437
New +$923K 0.02% 835
2022
Q1 		– Sell
-34,703
Closed -$940K – 3730
2021
Q4 		$940K Buy
+34,703
New +$1.04M 0.01% 1200

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HRT Financial's REPL Position: Q1 2026 in Review

HRT Financial sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 183,592 shares — an estimated $1.4M sold.

HRT Financial first reported a position in REPL in Q4 2021 and held it in 8 quarters. The position peaked at $2.7M in Q2 2023. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • HRT Financial reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 183,592 Replimune Group shares in Q1 2026, an estimated $1.4M.
  • HRT Financial first reported a position in Replimune Group in Q4 2021 and held it in 8 quarters.
  • HRT Financial's Replimune Group position peaked at $2.7M in Q2 2023.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.